-
1.
公开(公告)号:EP4171535A1
公开(公告)日:2023-05-03
申请号:EP21764572.0
申请日:2021-03-03
申请人: Sintetica S.A.
发明人: BORGEAT, Alain , MITIDIERI, Augusto , VENTURI, Miro , DONATI, Elisabetta , VOTTA-VELIS, E. Gina
IPC分类号: A61K31/167 , A61K31/485 , A61K9/00 , C07D489/00 , A61P25/00
-
公开(公告)号:EP3615012A1
公开(公告)日:2020-03-04
申请号:EP18789794.7
申请日:2018-04-25
申请人: Glover, Hillel , Hahn, Elliot
发明人: Glover, Hillel , Hahn, Elliot
IPC分类号: A61K31/025 , A61K31/047 , A61K31/435 , A61K31/485 , C07D489/00
-
公开(公告)号:EP3600321A1
公开(公告)日:2020-02-05
申请号:EP18777335.3
申请日:2018-03-27
申请人: Noramco, Inc.
发明人: CARDOT, Jessica , SASINE, Joshua , NICHOLS, Paul
IPC分类号: A61K31/485 , C07D489/00 , C07D489/02 , C07D489/04
-
公开(公告)号:EP2529739B1
公开(公告)日:2016-07-13
申请号:EP11737151.8
申请日:2011-01-28
发明人: KOBAYASHI, Ryosuke , NAKAO, Kaoru
IPC分类号: C07D489/00 , C07D489/08
CPC分类号: C07D489/00 , A61K31/485 , C07D489/02 , C07D489/08
-
公开(公告)号:EP2190819B1
公开(公告)日:2016-05-25
申请号:EP08797495.2
申请日:2008-08-08
发明人: WENTLAND, Mark, P.
IPC分类号: C07D221/26 , C07D221/28 , C07D489/00 , A61K31/485
CPC分类号: A61K31/485 , C07D215/20 , C07D401/12 , C07D405/06 , C07D405/12 , C07D471/04 , C07D487/08 , C07D489/08 , C07D491/16 , C07D491/22
摘要: Compounds of formulas: are disclosed. The compounds are useful for ameliorating the side effects of therapeutic opiates.
摘要翻译: 公开的化合物:公开。 该化合物可用于改善治疗性阿片剂的副作用。
-
6.8-CARBOXAMIDO-SUBSTITUTED-2 , 6-METHANO-3-BENZAZOCINES AND 3 - CARBOXAMIDO- SUBSTITUTED MORPHANES AS OPIOID RECEPTOR BINDING AGENTS 有权
标题翻译: 8甲酰氨基取代的2,6亚甲基 - 3- benzazocines和3 - 甲酰氨基 - 取代MORPHANE AS阿片受体结合剂公开(公告)号:EP1924559B1
公开(公告)日:2014-04-16
申请号:EP06800266.6
申请日:2006-07-21
发明人: WENTLAND, Mark
IPC分类号: C07D221/26 , C07D221/28 , C07D489/00
CPC分类号: C07D471/04 , C07D211/32 , C07D221/22 , C07D221/26 , C07D221/28 , C07D223/04 , C07D241/04 , C07D401/12 , C07D403/10 , C07D489/00 , C07D489/08 , C07D489/09 , C07D489/12
-
公开(公告)号:EP1870413B1
公开(公告)日:2013-07-10
申请号:EP06715476.5
申请日:2006-03-09
发明人: UMEUCHI, Hideo , UENO, Koki , MIYAKAWA, Hiroshi
IPC分类号: C07D489/00 , A61K31/485 , A61P17/04 , A61P25/28
CPC分类号: C07D491/10 , A61K31/485
-
8.REDUCTIVE AMINATION OF 6-KETO NORMORPHINANS BY CATALYTIC HYDROGEN TRANSFER 有权
标题翻译: 6-酮 - NORMORPHINANEN的还原性胺化催化氢转移公开(公告)号:EP2440561A2
公开(公告)日:2012-04-18
申请号:EP10724655.5
申请日:2010-06-10
申请人: Mallinckrodt LLC
发明人: GROTE, Christopher, W. , CANTRELL, Gary, L. , MCCLURG, Joseph, P. , THOMASSON, Catherine, E. , MOSER, Frank, W.
IPC分类号: C07D489/00 , C07B43/04
CPC分类号: C07D489/00 , C07D489/08
摘要: The present invention provides processes for the stereoselective synthesis of 6-alpha-amino morphinans. In particular, the invention provides processes for the reductive amination of 6-keto normorphinans by catalytic transfer hydrogenation.
-
公开(公告)号:EP2051740A1
公开(公告)日:2009-04-29
申请号:EP07800130.2
申请日:2007-08-16
发明人: GANT, Thomas, G. , SARSHAR, Sepehr
IPC分类号: A61K51/00 , C07D489/00
CPC分类号: C07D489/08 , A61K51/041 , A61K51/0455 , A61K51/0491 , C07B2200/05 , C07D489/02
摘要: The present disclosure is directed to modulators of opiate- and/or NMDA receptors and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the use of such compounds for the treatment and/or management of pain, anxiety, neurodegeneration, drug dependence, coughing, muscular tension, and/or glaucoma and any other condition in which it is beneficial to modulate an opiate- and/or NMDA receptor.
-
公开(公告)号:EP0897726A4
公开(公告)日:2003-05-28
申请号:EP97912539
申请日:1997-11-21
申请人: TORAY INDUSTRIES
发明人: NAGASE HIROSHI , UTSUMI JUN , ENDOH TAKASHI , TANAKA TOSHIAKI , KAMEI JUNZO , KAWAMURA KUNIAKI
IPC分类号: A61K31/40 , A61K31/4025 , A61K31/435 , A61K31/485 , A61K31/5377 , A61K31/541 , A61P17/04 , C07D489/00 , C07D489/08 , A61K45/00 , A61K31/54 , C07D279/12 , C07D295/14 , C07D491/08
CPC分类号: A61K31/541 , A61K31/40 , A61K31/4025 , A61K31/435 , A61K31/485 , A61K31/5377 , C07D489/00 , C07D489/08
摘要: An antipruritic agent comprising as the active ingredient an opioid λ receptor agonist useful for the treatment of pruritus in various diseases accompanied by pruritus, and novel morphinane quaternary ammonium salt derivatives and morphinane N-oxide derivatives.
-
-
-
-
-
-
-
-
-